Overcoming Barriers to Generic Drug Adoption: Insights from Global Studies

Objective: This review paper aims to provide insights into the awareness of generic drugs among consumers, challenges in the adoption of generic drugs identified in various studies conducted in different countries, and proposed remedies to make generic drugs more available, accessible, and affordable to consumers. Generic drugs, produced and marketed by entities other than the original innovators, are often priced significantly lower than branded drugs. However, patients sometimes exhibit reluctance towards generic versions. This article reviews findings, challenges, and potential solutions recorded in past research from sources like PubMed and Google Scholar. Data: Generic drugs are a vital component of healthcare affordability and accessibility, aligning with the United Nations' Sustainable Development Goals. We explore historical and evolving concepts of generic drugs, challenges posed by patenting, and the overarching issue of catastrophic medical expenditures. Study Selection: This review compiles information from diverse online sources, research articles, and review papers related to generic drugs. Conclusion: While generic drugs are equally effective and more affordable, consumers' awareness and perceptions often present barriers to adoption. Factors such as age, education level, health literacy, income, and trust in prescribers influence willingness to accept generic drugs. Country-specific healthcare policies, prescription regulatory frameworks, and reimbursement mechanisms also affect adoption. Addressing the perception of generic drugs, increasing knowledge, and improving educational interventions can enhance adoption. Making the prescription guidelines more binding and updating legal frameworks for generic substitution are essential steps. Generic drugs are a powerful tool for making healthcare more accessible and affordable, but these challenges must be overcome to realize their full potential.